http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2139896-C
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 1995-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbfc780183de0fb80024d444b906b357 |
| publicationDate | 2000-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2139896-C |
| titleOfInvention | Use of antinauseant agent for terminally ill humans |
| abstract | Disclosed herein is the use of a mixture of Doxylamine succinate and Pyridoxine HCl (Vitamin B6) in approximately equal weight ratios together with a pharmaceutically acceptable carrier to prevent and suppress the symptoms of nausea and vomiting among terminally ill individuals. |
| priorityDate | 1995-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.